Momenta
Johnson & Johnson seals largest pharmaceutical merger of the year by purchasing Momenta for $6.5 billion
August 20, 2020Business Services, Sales and Marketing Johnson and Johnson, Momenta
Johnson & Johnson is set to buy the Cambridge based Momenta Pharmaceuticals for $6.5 billion, making it the largest pharmaceutical …
Humira biosimilar proves efficacy in Phase 3 trial
November 30, 2016Research and Development AbbVie, Amgen, FDA, Humira, M923, Momenta
US-based biotechnology firm Momenta Pharmaceuticals has announced that its biosimilar version of Abbvie’s autoimmune drug Humira (adalimumab) – currently the …
Mylan announces Momenta collaboration to develop six biosimilars
January 8, 2016Manufacturing and Production, Sales and Marketing Heather Bresch, Momenta, Mylan, biosimilars
Mylan has entered an exclusive global collaboration agreement with Momenta Pharmaceuticals, to develop, manufacture and commercialise six of Momenta’s biosimilar …
Latest content
Five Facts about cardiovascular disease
August 9, 2026
